Business Wire

ESAB Corporation enters partnership with GRI to promote sustainability

12.7.2023 14:00:00 EEST | Business Wire | Press release

Share

ESAB Corporation (NYSE: ESAB), a world leader in connected fabrication technology and gas control solutions, and GRI Renewable Industries, a global leading manufacturer of wind turbine components, have entered a new partnership to collaborate on green projects in support of their mutual commitment to running sustainable businesses. The partnership will leverage each company’s expertise in the fabrication and wind power industries to drive initiatives such as the transition to green energy and the reduction of each company’s environmental footprint.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230712662690/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

ESAB Corporation announced today it has entered a new partnership with GRI Renewable Industries, a global leading manufacturer of wind turbine components. The two companies will collaborate on green projects in support of their mutual commitment to running sustainable businesses, including the transition to green energy and the reduction of each company’s environmental footprint. Pictured here: Olivier Biebuyck, President of ESAB Corporation’s Fabrication Technology platform; Antonio Barbosa, CEO at GRI Renewable Energy Industries; ESAB Corporation CEO, Shyam P. Kambeyanda. (Photo: Business Wire)

“ESAB is thrilled to build on our relationship with GRI, one of our long-standing customers, to develop and implement innovative solutions that will decrease our environmental impact,” said Shyam P. Kambeyanda, President and CEO, ESAB Corporation. “Our two companies share a commitment to reducing greenhouse gas emissions and creating eco-friendly products that make our world a better place to live, which aligns with ESAB’s purpose of Shaping the world we imagine.”

Antonio Barbosa, CEO at GRI Renewable Energy Industries, said: “The renewable energy sector is a pillar in the decarbonization of the economy, and GRI Renewable Industries, as a committed player in this sector, considers the value chain greenhouse gas emission reduction in the wind energy sector as a key element in the company strategy and purpose: Doing well by doing Green. This partnering agreement with ESAB will enable us to develop processes and products together.”

About ESAB Corporation

Founded in 1904, ESAB Corporation (NYSE: ESAB) is a world leader in connected fabrication technology and gas control solutions. Its rich history of innovative products, workflow solutions, and business system (EBX) allows the company to realize its purpose of Shaping the world we imagine. ESAB Corporation is based in North Bethesda, Maryland and employs approximately 9,000 associates, and serves customers in approximately 150 countries. To learn more, visit www.ESABcorporation.com .

About GRI

Since 2008, GRI Renewable Industries ( www.gri.com.es ) has been developing its core business of manufacturing wind towers and flanges in the wind energy sector. Currently, it has 18 manufacturing plants in Spain, USA, Brazil, Argentina, China, Turkey, India, and South Africa supplying high-quality wind towers and flanges to the wind energy industry worldwide. The company closed 2022 with sales around 1,200 million euros and over 5,500 employees.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

ESAB Media Contact:
Tilea Coleman
Vice President, Corporate Communications
E-mail: mediarelations@esab.com
Phone: 1-301-323-9092

GRI Media Contact:
Juan Llovet
Sustainability & Communications Director
Email: juan.llovet@gonvarri.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Empire State Building Observation Deck to Debut ‘Olympus Awaits,’ An Immersive ‘Percy Jackson and the Olympians’ Takeover in the Heart of NYC, On Display from Nov. 16 – Dec. 4*13.11.2026 00:07:00 EET | Press release

The Empire State Building (ESB) is the gateway to Mount Olympus in Percy Jackson’s world, and now fans can experience the magic like never before. On Nov. 16, the Empire State Building Observation Deck (ESBOD) will unveil “Olympus Awaits,” a multi-level “Percy Jackson and the Olympians” takeover, in partnership with Disney+. The immersive takeover – included with every Observation Deck ticket – will feature an epic Throne Room, interactive photo opportunities, surprise giveaways, ESB x “Percy Jackson” merch, and more, available through Dec. 4, 2026.* This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112442266/en/ Empire State Building Observation Deck to Debut ‘Olympus Awaits,’ An Immersive ‘Percy Jackson and the Olympians’ Takeover in the Heart of NYC, On Display from Nov. 16 – Dec. 4* “This immersive NYC experience brings Percy Jackson’s adventures off the screen and into the ‘World’s Most Famous Building,’ where guests ca

Clene Nanomedicine Partners with Veristat to Reduce Biostatistical Output Time by 80% for ALS New Drug Application12.11.2026 19:09:00 EET | Press release

VeristatTM, a global clinical research organization (CRO) and consultancy specializing in complex studies, announced that it has partnered with Clene Nanomedicine to cut the time to deliver biostatistical outputs for a pivotal ALS drug application submission by 80%. Veristat reduced the time from study data to validated tables, listings and figures (TLFs) from up to six weeks to just one week. Clene, a late-stage biotech company, leveraged Veristat’s recently launched InStat™ platform, the industry’s first zero-code, fully automated solution to accelerate clinical trial processes. Biostatistical TLFs sit on the critical path for submissions, yet most sponsors rely on antiquated processes that involve slow, manual workflows to produce them, making post-database lock one of the biggest bottlenecks to regulatory approval. To remove this barrier, Veristat uses its AI-enhanced platform to compress the timeline to submission-ready TLFs from weeks to days, with every output validated by stati

WHOOP Launches WHOOP Humans, the Most Verifiably Human Social Network12.11.2026 19:00:00 EET | Press release

WHOOP, the human performance brand, today launched WHOOP Humans, a new feature that lets members follow friends and family, share fitness, health, and performance data they choose, and support each other's progress. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112176779/en/ WHOOP Launches WHOOP Humans, the Most Verifiably Human Social Network For more than a decade, WHOOP has helped members better understand their own health and performance. Now, WHOOP Humans extends that experience beyond the individual, making it easier to celebrate achievements, encourage progress, and look out for the people who matter most. "In a world that's becoming increasingly artificial, we're building something deeply human,” said Will Ahmed, Founder and CEO of WHOOP. “This is the most verifiably human network ever launched. Every account represents a real person with a verified heartbeat. They have real goals, challenges, and achievements. T

Integrated Hubs for Green Chemistry Research Aim to Transform How Chemicals and Materials Are Designed12.11.2026 18:00:00 EET | Press release

The Gordon and Betty Moore Foundation today announced four Integrated Research Hubs to explore new frontiers in chemical design, from materials that respond to their surroundings to molecules designed for safety from the start. Bringing together global researchers across institutions and disciplines, the hubs will investigate fundamental principles that could enable new capabilities in chemicals and materials while improving performance and protecting human health and the environment. The research priorities emerged through extensive engagement with the scientific community to identify the questions that could transform what chemistry can achieve. Each hub will connect researchers across institutions around one of four green chemistry focus areas: Safer molecular design: Led by The George Washington University, this hub will combine artificial intelligence and quantum chemistry to embed safety into chemical design from the outset. Adaptive catalytic systems: Led by the Max Planck Insti

Roquette Highlights Scalable Excipient and Capsule Solutions for Regional and Global Pharmaceutical Markets at CPHI India 202612.11.2026 17:00:00 EET | Press release

Roquette, a global leader in plant-based ingredients and a leading provider of pharmaceutical excipients, will showcase its comprehensive portfolio of excipient and capsule solutions at CPHI India 2026, Hall 1, Booth 1I12 from November 23 to 25, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112803410/en/ Meet Roquette at CPHI India 2026, Hall 1, Booth 1I12 At the event, Roquette will demonstrate how it helps pharmaceutical manufacturers accelerate the journey from formulation to market with confidence. By combining technical expertise, trusted quality, meaningful innovation and close collaboration, Roquette helps customers address formulation, scale-up and manufacturing challenges across a broad range of pharmaceutical applications. As India continues to play a critical role in supplying medicines to patients around the world, pharmaceutical manufacturers face increasing demands for quality, regulatory compliance,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye